| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shi-Wei Xu, Min Dong, Qinge Zhang, Shu-Yu Yang, Lian-Yu Chen, Kang Sim, Yan-Ling He, Helen Fk Chiu, Norman Sartorius, Chay-Hoon Tan, Mian-Yoon Chong, Naotaka Shinfuku, Shih-Ku Lin, Chee H Ng, Gabor S Ungvari, Eunice Najoan, Roy Abraham Kallivayalil, Ruzita Jamaluddin, Afzal Javed, Hitoshi Iida, Thiha Swe, Bin Zhang, Yu-Tao Xian. Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016). Psychiatry research. vol 287. 2020-09-28. PMID:30885383. |
clozapine is an effective antipsychotic medication for treatment resistant schizophrenia and is widely used in asian countries. |
2020-09-28 |
2023-08-13 |
Not clear |
| Shi-Wei Xu, Min Dong, Qinge Zhang, Shu-Yu Yang, Lian-Yu Chen, Kang Sim, Yan-Ling He, Helen Fk Chiu, Norman Sartorius, Chay-Hoon Tan, Mian-Yoon Chong, Naotaka Shinfuku, Shih-Ku Lin, Chee H Ng, Gabor S Ungvari, Eunice Najoan, Roy Abraham Kallivayalil, Ruzita Jamaluddin, Afzal Javed, Hitoshi Iida, Thiha Swe, Bin Zhang, Yu-Tao Xian. Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016). Psychiatry research. vol 287. 2020-09-28. PMID:30885383. |
clozapine is frequently and increasingly prescribed for schizophrenia in asia, with large variation across countries and territories. |
2020-09-28 |
2023-08-13 |
Not clear |
| Shinichiro Ochi, Saori Inoue, Yuta Yoshino, Hideaki Shimizu, Jun-Ichi Iga, Shu-Ichi Uen. Efficacy of Asenapine in Schizophrenia Resistant to Clozapine Combined with Electroconvulsive Therapy: A Case Report. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 17. issue 4. 2020-09-28. PMID:31671497. |
efficacy of asenapine in schizophrenia resistant to clozapine combined with electroconvulsive therapy: a case report. |
2020-09-28 |
2023-08-13 |
Not clear |
| Megan K Skelly, Tammie Lee Demler, Claudia Le. High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure. Innovations in clinical neuroscience. vol 16. issue 7-08. 2020-09-28. PMID:31832260. |
clozapine, a second-generation antipsychotic (sga), is known for its superior efficacy in the treatment of refractory schizophrenia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Stefania Chiappini, Fabrizio Schifano, John Martin Corkery, Amira Guirgui. Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database. Brain sciences. vol 10. issue 2. 2020-09-28. PMID:32079135. |
clozapine is of high clinical relevance for the management of both treatment-resistant schizophrenia and psychotic disturbances with concurrent drug misuse. |
2020-09-28 |
2023-08-13 |
Not clear |
| Christielly Rodrigues-Silva, Agostinho Tavares Semedo, Hiasmin Franciely da Silva Neri, Rosana Pereira Vianello, Carlos Galaviz-Hernández, Martha Sosa-Macías, Rodrigo Bernini de Brito, Paulo César Ghedin. The CYP2C19*2 and CYP2C19*17 Polymorphisms Influence Responses to Clozapine for the Treatment of Schizophrenia. Neuropsychiatric disease and treatment. vol 16. 2020-09-28. PMID:32103962. |
the cyp2c19*2 and cyp2c19*17 polymorphisms influence responses to clozapine for the treatment of schizophrenia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Christielly Rodrigues-Silva, Agostinho Tavares Semedo, Hiasmin Franciely da Silva Neri, Rosana Pereira Vianello, Carlos Galaviz-Hernández, Martha Sosa-Macías, Rodrigo Bernini de Brito, Paulo César Ghedin. The CYP2C19*2 and CYP2C19*17 Polymorphisms Influence Responses to Clozapine for the Treatment of Schizophrenia. Neuropsychiatric disease and treatment. vol 16. 2020-09-28. PMID:32103962. |
clozapine (clz) is the gold standard drug for treatment-refractory schizophrenia (trs). |
2020-09-28 |
2023-08-13 |
Not clear |
| Juan Pablo Lucchelli, Stamatia Kourakou, Laia Pérez de Lucia Bové, Daniel Diaz Rodrigue. Lorazepam-Resistant Catatonia in an Antipsychotic-Naïve 24-Year-Old with Psychotic Symptoms. Case reports in psychiatry. vol 2020. 2020-09-28. PMID:32318305. |
we present the case of a 24-year-old man with severe catatonia and psychotic symptoms, resistant to lorazepam treatment, who achieved complete remission with clozapine treatment according to our diagnostic hypothesis of schizophrenia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Abhinav Garg, Anandbir S Bath, Jagadeesh K Kalavakunt. Non-ischemic Cardiomyopathy: A Rare Adverse Effect of Clozapine. Cureus. vol 12. issue 4. 2020-09-28. PMID:32494516. |
clozapine is a dibenzodiazepine antipsychotic used for treatment-resistant schizophrenia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Abhinav Garg, Anandbir S Bath, Jagadeesh K Kalavakunt. Non-ischemic Cardiomyopathy: A Rare Adverse Effect of Clozapine. Cureus. vol 12. issue 4. 2020-09-28. PMID:32494516. |
here we report an unusual case of clozapine-induced nonischemic dilated cardiomyopathy. a 50-year-old female with treatment-resistant schizophrenia on clozapine presented with gradually worsening shortness of breath, productive cough, and pleuritic chest pain. |
2020-09-28 |
2023-08-13 |
Not clear |
| Jitender Aneja, Vaibhav Varshney, Sreesanth Ks, Kartik Singhai, Taruna Yada. Clozapine Triggering Cecal Volvulus in a Patient With Malrotation and Schizophrenia: Side Effect That Needs Emphasis. Cureus. vol 12. issue 5. 2020-09-28. PMID:32523828. |
clozapine triggering cecal volvulus in a patient with malrotation and schizophrenia: side effect that needs emphasis. |
2020-09-28 |
2023-08-13 |
Not clear |
| Jitender Aneja, Vaibhav Varshney, Sreesanth Ks, Kartik Singhai, Taruna Yada. Clozapine Triggering Cecal Volvulus in a Patient With Malrotation and Schizophrenia: Side Effect That Needs Emphasis. Cureus. vol 12. issue 5. 2020-09-28. PMID:32523828. |
hereby, we report the case of a 24-year-old male, suffering from schizophrenia and being managed with clozapine, who developed symptoms of acute intestinal obstruction due to ceco-colic volvulus. |
2020-09-28 |
2023-08-13 |
Not clear |
| Siobhan Gee, Fiona Gaughran, James MacCabe, Sukhi Shergill, Eromona Whiskey, David Taylo. Management of clozapine treatment during the COVID-19 pandemic. Therapeutic advances in psychopharmacology. vol 10. 2020-09-28. PMID:32542111. |
clozapine is the only available treatment for refractory schizophrenia but its use involves frequent physical contact with healthcare workers for the purpose of mandatory blood monitoring. |
2020-09-28 |
2023-08-13 |
Not clear |
| Eromona Whiskey, Shirley Yuen, Emma Khosla, Susan Piper, David O'Flynn, David Taylo. Resolution without discontinuation: heart failure during clozapine treatment. Therapeutic advances in psychopharmacology. vol 10. 2020-09-28. PMID:32547730. |
clozapine is an atypical antipsychotic recommended for patients with treatment-resistant schizophrenia whose illness has not responded adequately to treatment despite the sequential use of at least two different antipsychotic drugs at therapeutic doses. |
2020-09-28 |
2023-08-13 |
Not clear |
| Remiko Kobayashi, Yasunori Oda, Ryunosuke Hayatsu, Nozomi Ohki, Misa Akutsu, Takahiro Oiwa, Hideki Komatsu, Tomihisa Niitsu, Tsuyoshi Sasaki, Masaomi Iy. Successful rechallenge with paliperidone after clozapine treatment for a patient with dopamine supersensitivity psychosis. SAGE open medical case reports. vol 8. 2020-09-28. PMID:32551117. |
we describe the case of a 49-year-old japanese male patient successfully treated with a paliperidone rechallenge following 2-year treatment with clozapine for treatment-resistant schizophrenia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Solomon Teferr. Initiating clozapine treatment service and characteristics of clozapine-treated patients in a general hospital in Addis Ababa, Ethiopia. The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa. vol 26. 2020-09-28. PMID:32670632. |
at least one-third of patients with schizophrenia suffer from treatment-resistant schizophrenia needing treatment with clozapine. |
2020-09-28 |
2023-08-13 |
Not clear |
| Catherine Gisi, Anamaria Munteanu, Lawrence Ku, Samuel French, Michael Fleischman, Viktor Eysselei. Atypical Presentation of Acquired Hypoganglionosis in a Patient Taking Clozapine. Case reports in gastrointestinal medicine. vol 2020. 2020-09-28. PMID:32670642. |
clozapine is an atypical antipsychotic used to treat refractory schizophrenia that is well known for its side effects including agranulocytosis and gastrointestinal dysmotility. |
2020-09-28 |
2023-08-13 |
Not clear |
| Xavier Boland, Luiz Dratc. Clozapine in the Time of COVID-19. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 18. issue 3. 2020-09-28. PMID:32702224. |
clozapine is the most effective antipsychotic for treatment resistant schizophrenia but adverse reactions to clozapine include neutropenia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Xavier Boland, Luiz Dratc. Clozapine in the Time of COVID-19. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 18. issue 3. 2020-09-28. PMID:32702224. |
we report on two actively psychotic patients with treatment resistant schizophrenia who required admission to our inner-london acute psychiatric unit during the covid-19 pandemic and who were treated with clozapine. |
2020-09-28 |
2023-08-13 |
Not clear |
| Olivia Morrow, Lucy Gibson, Manraj Bhamra, Anthony S David, Sotirios Posporeli. G-CSF mediated neutrophil augmentation in a unique case of comorbid idiopathic Parkinson's disease and treatment-resistant schizophrenia on clozapine. Therapeutic advances in psychopharmacology. vol 10. 2020-09-28. PMID:32973999. |
g-csf mediated neutrophil augmentation in a unique case of comorbid idiopathic parkinson's disease and treatment-resistant schizophrenia on clozapine. |
2020-09-28 |
2023-08-13 |
Not clear |